Sonodynamic therapy of glioblastoma mediated by platelets with ultrasound-triggered drug release

References

• Aldaz P, Arozarena I. (2021). Tyrosine kinase inhibitors in adult glioblastoma: an (un)closed chapter? Cancers (Basel) 13:1.
   Web of Science ®Google Scholar
• An J, Hu YG, Cheng K, et al. (2020). ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy. Biomaterials 234:119761.
   PubMed Web of Science ®Google Scholar
• Behzadpour N, Ranjbar A, Azarpira N, et al. (2020). Development of a composite of polypyrrole-coated carbon nanotubes as a sonosensitizer for treatment of melanoma cancer under multi-step ultrasound irradiation. Ultrasound Med Biol 46:2322–16.
   PubMed Web of Science ®Google Scholar
• Bohm AK, DePetro J, Binding CE, et al. (2020). In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors. Neuro Oncol 22:1150–61.
   PubMed Web of Science ®Google Scholar
• Campanella R, Guarnaccia L, Cordiglieri C, et al. (2020). Tumor-educated platelets and angiogenesis in glioblastoma: another brick in the wall for novel prognostic and targetable biomarkers, changing the vision from a localized tumor to a systemic pathology. Cells 9:294.
   PubMed Web of Science ®Google Scholar
• Di Vito C, Navone SE, Marfia G, et al. (2017). Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release. Platelets 28:585–94.
   PubMed Web of Science ®Google Scholar
• Fisher JP, Adamson DC. (2021). Current FDA-approved therapies for high-grade malignant gliomas. Biomedicines 9:324.
   PubMed Web of Science ®Google Scholar
• Golebiewska EM, Poole AW. (2015). Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29:153–62.
   PubMed Web of Science ®Google Scholar
• Gomes de Azevedo-Quintanilha I, Campos MM, Teixeira Monteiro AP, et al. (2022). Increased platelet activation and platelet-inflammasome engagement during chikungunya infection. Front Immunol 13:958820.
   PubMed Web of Science ®Google Scholar
• Han X, Chen J, Chu J, et al. (2019). Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody. J Control Release 304:233–41.
   PubMed Web of Science ®Google Scholar
• Huang Y, Joshi S, Xiang B, et al. (2016). Arf6 controls platelet spreading and clot retraction via integrin alphaIIbbeta3 trafficking. Blood 127:1459–67.
   PubMed Web of Science ®Google Scholar
• Katsevman GA, Turner RC, Urhie O, et al. (2019). Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival. J Neurosurg 132:914–20.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Z, Chen Z, et al. (2021). Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis. Nat Commun 12:2773.
   PubMed Web of Science ®Google Scholar
• Li L, Fu J, Wang X, et al. (2021). Biomimetic “Nanoplatelets” as a targeted drug delivery platform for breast cancer theranostics. ACS Appl Mater Interfaces 13:3605–21.
   PubMed Web of Science ®Google Scholar
• Li QR, Xu HZ, Xiao RC, et al. (2022). Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery. Drug Deliv 29:937–49.
   PubMed Web of Science ®Google Scholar
• Li TF, Li K, Wang C, et al. (2017). Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. J Control Release 268:128–46.
   PubMed Web of Science ®Google Scholar
• Li TF, Li K, Zhang Q, et al. (2018). Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials 181:35–52.
   PubMed Web of Science ®Google Scholar
• Li TF, Xu HZ, Xu YH, et al. (2021). Efficient delivery of chlorin e6 by polyglycerol-coated iron oxide nanoparticles with conjugated doxorubicin for enhanced photodynamic therapy of melanoma. Mol Pharm 18:3601–15.
   PubMedGoogle Scholar
• Liang K, Li Z, Luo Y, et al. (2020). Intelligent nanocomposites with intrinsic blood-brain-barrier crossing ability designed for highly specific MR imaging and sonodynamic therapy of glioblastoma. Small 16:e1906985.
   PubMed Web of Science ®Google Scholar
• Liao S, Cai M, Zhu R, et al. (2023). Antitumor effect of photodynamic therapy/sonodynamic therapy/sono-photodynamic therapy of chlorin e6 and other applications. Mol Pharm 20:875–85.
   PubMedGoogle Scholar
• Lv Y, Li F, Wang S, et al. (2021). Near-infrared light-triggered platelet arsenal for combined photothermal-immunotherapy against cancer. Sci Adv 7(13):eabd7614.
   Web of Science ®Google Scholar
• Nambiar N, Nagireddy PKR, Pedapati R, et al. (2020). Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine. Life Sci 258:118238.
   PubMed Web of Science ®Google Scholar
• Nguyen Cao TG, Kang JH, You JY, et al. (2021). Safe and targeted sonodynamic cancer therapy using biocompatible exosome-based nanosonosensitizers. ACS Appl Mater Interfaces 13:25575–88.
   PubMed Web of Science ®Google Scholar
• Pei W, Huang B, Chen S, et al. (2020). Platelet-mimicking drug delivery nanoparticles for enhanced chemo-photothermal therapy of breast cancer. Int J Nanomedicine 15:10151–67.
   PubMed Web of Science ®Google Scholar
• Qiao J, Arthur JF, Gardiner EE, et al. (2018). Regulation of platelet activation and thrombus formation by reactive oxygen species. Redox Biol 14:126–30.
   PubMed Web of Science ®Google Scholar
• Qu F, Wang P, Zhang K, et al. (2020). Manipulation of Mitophagy by “All-in-One” nanosensitizer augments sonodynamic glioma therapy. Autophagy 16:1413–35.
   PubMed Web of Science ®Google Scholar
• Shono K, Mizobuchi Y, Yamaguchi I, et al. (2021). Elevated cellular PpIX potentiates sonodynamic therapy in a mouse glioma stem cell-bearing glioma model by downregulating the Akt/NF-kappaB/MDR1 pathway. Sci Rep 11:15105.
   PubMed Web of Science ®Google Scholar
• Stadlbauer A, Kinfe TM, Eyupoglu I, et al. (2021). Tissue hypoxia and alterations in microvascular architecture predict glioblastoma recurrence in humans. Clin Cancer Res 27:1641–9.
   PubMed Web of Science ®Google Scholar
• Wang C, Li K, Li T, et al. (2018). Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine (Lond) 13:157–78.
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Wang P, et al. (2017). Current status and future perspectives of sonodynamic therapy in glioma treatment. Ultrason Sonochem 37:592–9.
   PubMed Web of Science ®Google Scholar
• Wu SK, Santos MA, Marcus SL, et al. (2019). MR-guided focused ultrasound facilitates sonodynamic therapy with 5-aminolevulinic acid in a rat glioma model. Sci Rep 9:10465.
   PubMed Web of Science ®Google Scholar
• Xie B, Zhang L, Hu W, et al. (2019). Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells. Redox Biol 24:101189.
   PubMed Web of Science ®Google Scholar
• Xu HZ, Li TF, Ma Y, et al. (2022). Targeted photodynamic therapy of glioblastoma mediated by platelets with photo-controlled release property. Biomaterials 290:121833.
   PubMed Web of Science ®Google Scholar
• Zanders ED, Svensson F, Bailey DS. (2019). Therapy for glioblastoma: is it working? Drug Discov Today 24:1193–201.
   PubMed Web of Science ®Google Scholar